Two-year follow-up in patients treated with emphysematous lung sealant for advanced emphysema

Chest

Volumn 144, Issue 5, 2013, Pages 1677-1680

  Kramer, Mordechai R ^a   Refaely, Yael ^b   Maimon, Nimrod ^b   Rosengarten, Dror ^a   Fruchter, Oren ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; EMPHYSEMATOUS LUNG SEALANT; SEALANT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE STUDY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; SAFETY; TREATMENT RESPONSE;

EID: 84887474502     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-0446     Document Type: Article

References (12)

1. Toma TP. Lung-volume reduction. Lancet. 2001;357(9268):1621.
2. Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet. 2003;361(9361):931-933.
3. Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proc Am Thorac Soc. 2008;5(4):454-460.
4. Fessler HE. Collateral ventilation, the bane of bronchoscopic volume reduction. Am J Respir Crit Care Med. 2005;171(5):423-424.
5. Herth FJ, Ernst A, Baker KM, et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis. 2012;7:397-405.
6. Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest. 2012;142(3):574-582.
7. Sterman DH, Mehta AC, Wood DE, et al; IBV Valve US Pilot Trial Research Team. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration. 2010;79(3):222-233.
8. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest. 2012;142(5):1111-1117.
9. Aeris Therapeutics. A study of the AeriSeal® system administered at 3 to 4 sites during a single treatment session for lung volume reduction in patients with advanced emphysema. NCT01181466. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2010. http://clinicaltrials.gov/show/ NCT01181466. Updated October 20, 2011.
10. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549-555.
11. Aeris Therapeutics. Post market registry study of the AeriSeal system. NCT01520064. ClinicalTrials.gov. Bethesda, MD: National Institutes of Health; 2012. http://clinicaltrials.gov/ct2/show/NCT01520064. Updated March 22, 2013.
12. Brenner M, McKenna RJ Jr, Gelb AF, Fischel RJ, Wilson AF. Rate of FEV 1 change following lung volume reduction surgery. Chest. 1998;113(3):652-659.